Promoter variant of angiopoietin-2 and plasma angiopoietin-2 are associated with risk of stroke recurrence in lacunar infarct patients

Biochemical and Biophysical Research Communications

Volumn 398, Issue 2, 2010, Pages 212-216

  Chen, Jingzhou ^a   Yu, Hui ^a   Sun, Kai ^a   Song, Weihua ^a   Bai, Yongyi ^a   Yang, Tao ^a   Song, Yan ^a   Zhang, Yinhui ^a   Hui, Rutai ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Angiopoietin 2; Follow up study; Lacunar infarction; Stroke recurrence

Indexed keywords

ANGIOPOIETIN 2;

ADULT; AGED; ALLELE; ARTICLE; BRAIN ATHEROSCLEROSIS; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN VENTRICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; RECURRENCE RISK; SIGNAL TRANSDUCTION; STROKE;

AGED; ALLELES; ANGIOPOIETIN-2; BIOLOGICAL MARKERS; BRAIN INFARCTION; CHINA; FEMALE; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROMOTER REGIONS, GENETIC; RECURRENCE; RISK; STROKE;

EID: 77955055363     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.06.062     Document Type: Article

References (34)

1. Tunstall-Pedoe H., Kuulasmaa K., Amouyel P., Arveiler D., Rajakangas A.M., Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994, 90:583-612.
2. Kiyohara Y., Kubo M., Kato I., Tanizaki Y., Tanaka K., Okubo K., Nakamura H., Iida M. Ten-year prognosis of stroke and risk factors for death in a Japanese community: the Hisayama study. Stroke 2003, 34:2343-2347.
3. Lai S.M., Alter M., Friday G., Sobel E. A multifactorial analysis of risk factors for recurrence of ischemic stroke. Stroke 1994, 25:958-962.
4. Grau A.J., Boddy A.W., Dukovic D.A., Buggle F., Lichy C., Brandt T., Hacke W. Leukocyte count as an independent predictor of recurrent ischemic events. Stroke 2004, 35:1147-1152.
5. Elkind M.S., Tai W., Coates K., Paik M.C., Sacco R.L. High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke. Arch. Intern. Med. 2006, 166:2073-2080.
6. Fiedler U., Reiss Y., Scharpfenecker M., Grunow V., Koidl S., Thurston G., Gale N.W., Witzenrath M., Rosseau S., Suttorp N., Sobke A., Herrmann M., Preissner K.T., Vajkoczy P., Augustin H.G. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat. Med. 2006, 12:235-239.
7. Fiedler U., Scharpfenecker M., Koidl S., Hegen A., Grunow V., Schmidt J.M., Kriz W., Thurston G., Augustin H.G. The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood 2004, 103:4150-4156.
8. Scharpfenecker M., Fiedler U., Reiss Y., Augustin H.G. The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J. Cell Sci. 2005, 118:771-780.
9. Kim I., Kim H.G., So J.N., Kim J.H., Kwak H.J., Koh G.Y. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Circ. Res. 2000, 86:24-29.
10. Papapetropoulos A., Fulton D., Mahboubi K., Kalb R.G., O'Connor D.S., Li F., Altieri D.C., Sessa W.C. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J. Biol. Chem. 2000, 275:9102-9105.
11. Thurston G., Rudge J.S., Ioffe E., Zhou H., Ross L., Croll S.D., Glazer N., Holash J., McDonald D.M., Yancopoulos G.D. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 2000, 6:460-463.
12. Thurston G., Suri C., Smith K., McClain J., Sato T.N., Yancopoulos G.D., McDonald D.M. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999, 286:2511-2514.
13. Fiedler U., Augustin H.G. Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol. 2006, 27:552-558.
14. Fiedler U., Krissl T., Koidl S., Weiss C., Koblizek T., Deutsch U., Martiny-Baron G., Marme D., Augustin H.G. Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats. J. Biol. Chem. 2003, 278:1721-1727.
15. Parikh S.M., Mammoto T., Schultz A., Yuan H.T., Christiani D., Karumanchi S.A., Sukhatme V.P. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med. 2006, 3:e46.
16. Li Z., Sun L., Zhang H., Liao Y., Wang D., Zhao B., Zhu Z., Zhao J., Ma A., Han Y., Wang Y., Shi Y., Ye J., Hui R. Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a multicenter case-control study in China. Stroke 2003, 34:2085-2090.
17. Chong A.Y., Caine G.J., Freestone B., Blann A.D., Lip G.Y. Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure. J. Am. Coll. Cardiol. 2004, 43:423-428.
18. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988, 16:1215.
19. Chen J., Yu H., Song W., Sun K., Song Y., Lou K., Yang T., Zhang Y., Hui R. Angiopoietin-2 promoter haplotypes confer an increased risk of stroke in a Chinese Han population. Clin. Sci. (Lond.) 2009, 117:387-395.
20. Hassan A., Hunt B.J., O'Sullivan M., Parmar K., Bamford J.M., Briley D., Brown M.M., Thomas D.J., Markus H.S. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 2003, 126:424-432.
21. Benavente O., White C.L., Roldan A.M. Small vessel strokes. Curr. Cardiol. Rep. 2005, 7:23-28.
22. Norrving B. Long-term prognosis after lacunar infarction. Lancet Neurol. 2003, 2:238-245.
23. Jackson C., Sudlow C. Comparing risks of death and recurrent vascular events between lacunar and non-lacunar infarction. Brain 2005, 128:2507-2517.
24. Arboix A., Font A., Garro C., Garcia-Eroles L., Comes E., Massons J. Recurrent lacunar infarction following a previous lacunar stroke: a clinical study of 122 patients. J. Neurol. Neurosurg. Psychiatry 2007, 78:1392-1394.
25. Soda T., Nakayasu H., Maeda M., Kusumi M., Kowa H., Awaki E., Saito J., Nakashima K. Stroke recurrence within the first year following cerebral infarction - Tottori University Lacunar Infarction Prognosis Study (TULIPS). Acta Neurol. Scand. 2004, 110:343-349.
26. Nakase T., Yamazaki T., Ogura N., Suzuki A., Nagata K. The impact of inflammation on the pathogenesis and prognosis of ischemic stroke. J. Neurol. Sci. 2008, 271:104-109.
27. Lemieux C., Maliba R., Favier J., Theoret J.F., Merhi Y., Sirois M.G. Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses. Blood 2005, 105:1523-1530.
28. Sturn D.H., Feistritzer C., Mosheimer B.A., Djanani A., Bijuklic K., Patsch J.R., Wiedermann C.J. Angiopoietin affects neutrophil migration. Microcirculation 2005, 12:393-403.
29. Liu T., Clark R.K., McDonnell P.C., Young P.R., White R.F., Barone F.C., Feuerstein G.Z. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 1994, 25:1481-1488.
30. Orfanos S.E., Kotanidou A., Glynos C., Athanasiou C., Tsigkos S., Dimopoulou I., Sotiropoulou C., Zakynthinos S., Armaganidis A., Papapetropoulos A., Roussos C. Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators. Crit. Care Med. 2007, 35:199-206.
31. Hangai M., He S., Hoffmann S., Lim J.I., Ryan S.J., Hinton D.R. Sequential induction of angiogenic growth factors by TNF-alpha in choroidal endothelial cells. J. Neuroimmunol. 2006, 171:45-56.
32. Kim I., Kim J.H., Ryu Y.S., Liu M., Koh G.Y. Tumor necrosis factor-alpha upregulates angiopoietin-2 in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 2000, 269:361-365.
33. van der Heijden M., van Nieuw Amerongen G.P., Chedamni S., van Hinsbergh V.W., Johan Groeneveld A.B. The angiopoietin-Tie2 system as a therapeutic target in sepsis and acute lung injury. Expert Opin. Ther. Targets 2009, 13:39-53.
34. Nomura S., Shouzu A., Omoto S., Inami N., Ueba T., Urase F., Maeda Y. Effects of eicosapentaenoic acid on endothelial cell-derived microparticles, angiopoietins and adiponectin in patients with type 2 diabetes. J. Atheroscler. Thromb. 2009, 16:83-90.